TNFAIP8 expression was higher in patients with newly diagnosed AML (n = 28, P < 0.05) and patients with relapsed/refractory AML (n = 13, P < 0.001) than in patients with complete remission (n = 19, Fig. 1b). The gene discussed is TNFAIP8; the disease is acute myeloid leukemia.